Human T-lymphotropic virus types 1 and 2 are rare among intravenous drug users in Eastern Europe

In Europe, human T-lymphotropic virus (HTLV) type 2 mainly occurs among intravenous drug users (IDUs) with prevalence up to 15% and HTLV-1 among general population with prevalence

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Infection, genetics and evolution genetics and evolution, 2016-09, Vol.43, p.83-85
Hauptverfasser:	Jõgeda, Ene-Ly, Avi, Radko, Pauskar, Merit, Kallas, Eveli, Karki, Tõnis, Des Jarlais, Don, Uusküla, Anneli, Lutsar, Irja, Huik, Kristi
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult at-risk population Blood-borne infection Co-infection Coinfection - epidemiology drugs Eastern European region Estonia Europe, Eastern Female genotype hepatitis B Hepatitis B - epidemiology hepatitis C Hepatitis C - epidemiology HIV HIV Infections - epidemiology HTLV-1/2 HTLV-I Infections - epidemiology HTLV-I Infections - virology HTLV-II Infections - epidemiology HTLV-II Infections - virology Human immunodeficiency virus Human T-lymphotropic virus 1 - genetics Human T-lymphotropic virus 1 - isolation & purification Human T-lymphotropic virus 2 - genetics Human T-lymphotropic virus 2 - isolation & purification Humans intravenous injection Male males Middle Aged Needle Sharing - statistics & numerical data polymerase chain reaction Prevalence Primate T-lymphotropic virus 1 Primate T-lymphotropic virus 2 Substance Abuse, Intravenous - virology viruses volunteers
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!